# OnCo record idea-chemo-free-hodgkin (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-chemo-free-hodgkin/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-chemo-free-hodgkin" ;
  schema:name "Chemotherapy-free Hodgkin lymphoma: brentuximab + PD-1 in early stage"@en ;
  schema:description "For a cancer already cured in 90% of young people, the goal is curing without the chemotherapy and radiation that cause heart disease and second cancers decades later."@en ;
  schema:url <https://onco.cc/ideas/idea-chemo-free-hodgkin/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05675410> ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/pet-adapted-therapy/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/ctdna-lymphoma-monitoring/> ;
  onco:drugs <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/drugs/nivolumab/> ;
  onco:trials <https://onco.cc/trials/ahod2131/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-brentuximab-vedotin-hodgkin-lymphoma-lancet-oncol-2016/>, <https://onco.cc/key-papers/paper-checkmate-205-nivolumab-rr-hodgkin-extended-follow-up-jco-2018/>, <https://onco.cc/key-papers/paper-brentuximab-vedotin-hodgkin-lymphoma-blood-2018/> .